Stock listing
Argenica Therapeutics Ltd
Selected listing: AGN · ASX · AUD · AU
Argenica Therapeutics Ltd (ASX:AGN), Health Technology. Latest release Aug 26, 2026: Appendix 4E & Annual Report to 30 June 2026.
- Ticker
- ASX:AGN
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- ASX
- Currency
- AUD
About Argenica Therapeutics Ltd
Argenica Therapeutics Ltd is a public company listed on the Australian market under the ticker AGN. Argenica focuses on developing innovative therapeutics, although specific product details and financial performance metrics are not provided.
Latest news from Argenica Therapeutics Ltd
Appendix 4E & Annual Report to 30 June 2026
August 26, 2026
ARG007 Shows Significant Neuroprotection in Concussion Study
July 15, 2026
ARG007 (Xaranetide) Completes All Three FDA Requested Assays
June 10, 2026
WHO Confirms Xaranetide as INN for ARG-007
June 9, 2026
IND Application Advanced With Successful Completion of Assay
May 20, 2026
Research Argenica Therapeutics Ltd
Argenica Therapeutics Ltd company profile
View the public company page for Argenica Therapeutics Ltd on 6ix.
Argenica Therapeutics Ltd news
Read company news and market updates connected to Argenica Therapeutics Ltd.
Argenica Therapeutics Ltd investor events
Find investor webinars, events, and replay context for Argenica Therapeutics Ltd.